Health and Healthcare

ImmunoGen : IMGN

All IMGN Articles

66 Articles

Chris Lange | May 12, 2016 at 7:40 AM EDT

ASCO Could Make or Break These 7 Cancer Drug Trials

The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society…

Paul Ausick | May 2, 2016 at 4:04 PM EDT

The 52-Week Low Club for Monday

May 2, 2016: Here are four stocks trading with relatively heavy volume among 24 equities making new 52-week lows in…

Paul Ausick | Apr 29, 2016 at 4:04 PM EDT

The 52-Week Low Club for Friday

April 29, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in…

Lee Jackson | Dec 2, 2015 at 10:20 AM EST

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical…

Jon C. Ogg | Nov 25, 2015 at 8:42 AM EST

Top Analyst Upgrades and Downgrades: AmEx, Carnival, eBay, HP, IAMGOLD, Pfizer, Tech Data and Many More

Stocks were indicated surprisingly higher after international markets recovered more than might have been expected. The trend that has been…

Jon C. Ogg | Aug 3, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Arch Coal, Autodesk, CarMax, Coach, ExxonMobil, Disney, Whiting and More

Monday's top analyst upgrades downgrades and initiations include Arch Coal, Autodesk, CarMax, Coach, Exxon Mobil, Walt Disney and Whiting Petroleum.

Chris Lange | Jun 7, 2015 at 9:10 AM EDT

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

24/7 Wall St. has taken a look at some of the major ASCO winners over the past week and how…

Chris Lange | Jun 1, 2015 at 9:40 AM EDT

6 Key Cancer Winners From ASCO Presentations

24/7 Wall St. has taken a look at a few of the major ASCO winners so far. Color and background…

Chris Lange | May 14, 2015 at 3:08 PM EDT

The 5 Winners and Losers From ASCO Presentations

Investors, doctors and cancer patients are anxiously awaiting some of the key presentations and abstracts from the American Society of…

Jon C. Ogg | Feb 7, 2015 at 10:35 AM EST

5 Analyst Stock Picks Under $10 With Massive Upside Projections

Here are this past week's five analyst picks under $10 with colossal upside featured by 24/7 Wall St.

Jon C. Ogg | Dec 27, 2014 at 9:20 AM EST

13 Analyst Stocks at $10 and Under With Huge Implied Upside

Many investors are looking for where to put their money now that the Dow Jones Industrial Average has hit 18,000.

Paul Ausick | Dec 19, 2014 at 4:05 PM EST

The 52-Week Low Club for Friday

ThinkstockDecember 19, 2014: Here are four stocks among the 55 equities making new 52-week lows today. Ascena Retail Group Inc.…

Lee Jackson | Sep 3, 2014 at 8:55 AM EDT

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

A Cowen report zeroes in on the most illiquid stocks that will be traded Wednesday as 15 ETFs rebalance.

Jon C. Ogg | Jun 25, 2014 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, June 25, 2014. They include Apple, Coach,…

Jon C. Ogg | Jun 12, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple,…

1 2 3 4 5

ImmunoGen : IMGN

All IMGN Articles

ASCO Could Make or Break These 7 Cancer Drug Trials

The 52-Week Low Club for Monday

The 52-Week Low Club for Friday

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

Top Analyst Upgrades and Downgrades: AmEx, Carnival, eBay, HP, IAMGOLD, Pfizer, Tech Data and Many More

Top Analyst Upgrades and Downgrades: Arch Coal, Autodesk, CarMax, Coach, ExxonMobil, Disney, Whiting and More

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

6 Key Cancer Winners From ASCO Presentations

The 5 Winners and Losers From ASCO Presentations

5 Analyst Stock Picks Under $10 With Massive Upside Projections

13 Analyst Stocks at $10 and Under With Huge Implied Upside

The 52-Week Low Club for Friday

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

ImmunoGen : IMGN

All IMGN Articles

ASCO Could Make or Break These 7 Cancer Drug Trials

The 52-Week Low Club for Monday

The 52-Week Low Club for Friday

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

Top Analyst Upgrades and Downgrades: AmEx, Carnival, eBay, HP, IAMGOLD, Pfizer, Tech Data and Many More

Top Analyst Upgrades and Downgrades: Arch Coal, Autodesk, CarMax, Coach, ExxonMobil, Disney, Whiting and More

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

6 Key Cancer Winners From ASCO Presentations

The 5 Winners and Losers From ASCO Presentations

5 Analyst Stock Picks Under $10 With Massive Upside Projections

13 Analyst Stocks at $10 and Under With Huge Implied Upside

The 52-Week Low Club for Friday

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026